Israeli study finds Omicron COVID booster cuts hospitalization in 65+
The Omicron-adapted COVID-19 vaccine booster developed by Pfizer Inc PFE.N and BioNTech SE 22UAy.DEsharply reduced hospitalizations among older patients, Israeli researchers said on Monday, in some of the first evidence of the jab’s real-world effectiveness. The study by researchers from healthcare provider Clalit, Ben-Gurion University of the Negev and Sapir College has not yet been […]
Continue Reading